Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ADXS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Advaxis stock price on Wednesday moving between $0.536 and $0.700
(Updated on Mar 27, 2024)

Sell candidate since Mar 11, 2024 Loss -2.78% PDF

The Advaxis stock price fell by -1.41% on the last day (Wednesday, 27th Mar 2024) from $0.710 to $0.700. During the last trading day the stock fluctuated 30.72% from a day low at $0.536 to a day high of $0.700. The price has fallen in 6 of the last 10 days. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -246 shares and in total, 24 thousand shares were bought and sold for approximately $16.71 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.598 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 9.12% during the next 3 months and, with a 90% probability hold a price between $0.652 and $1.50 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ADXS Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, March 21, 2024, and so far it has risen 18.64%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Advaxis stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.779. On a fall, the stock will find some support from the short-term average at $0.636. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Advaxis stock

Advaxis finds support from accumulated volume at $0.680 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.165 between high and low, or 30.72%. For the last week the stock has had daily average volatility of 18.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ADXS) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Advaxis to open at $0.645, and during the day (based on 14 day Average True Range), to move between $0.605 and $0.795, which gives a possible trading interval of +/-$0.0948 (+/-13.54%) up or down from last closing price. If Advaxis takes out the full calculated possible swing range there will be an estimated 27.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.680 (2.86%) than the resistance at $0.788 (12.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Advaxis stock A Buy?

Advaxis holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.969 Sell Candidate Unchanged

Predicted Opening Price for Advaxis of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.645 ( 7.83%) $0.700

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ADXS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.81 15.67 %
R2 0.747 6.69 %
R1 0.708 1.14 %
Current price: 0.700
Support S1 0.582 -16.81 %
S2 0.544 -22.36 %
S3 0.481 -31.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.86 23.00 %
R2 0.85 21.69 %
R1 0.788 12.57 %
Current price 0.700
Support S1 0.680 -2.86%
S2 0.670 -4.29%
S3 0.590 -15.71%

FAQ

What is the symbol for Advaxis Stock and on which exchange is it traded?
The symbol for Advaxis is ADXS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Advaxis Stock?
Advaxis holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Advaxis Stock?
Advaxis Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Advaxis Stock.

What's the current price of Advaxis Stock?
As of the end of day on the 2024-03-27, the price of an Advaxis (ADXS) share was $0.700.

What is the 52-week high and low for Advaxis Stock?
The 52-week high for Advaxis Stock is $1.95 and the 52-week low is $0.511.

What is the market capitalization of Advaxis Stock?
As of the 2024-03-27, the market capitalization of Advaxis is 29.843M.

When is the next earnings date for Advaxis?
The upcoming earnings date for Advaxis is May 21, 2024.
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT